Rita J Desai
Examiner (ID: 14900, Phone: (571)272-0684 , Office: P/1625 )
Most Active Art Unit | 1625 |
Art Unit(s) | 1612, 1625 |
Total Applications | 2152 |
Issued Applications | 1290 |
Pending Applications | 146 |
Abandoned Applications | 716 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 11032855
[patent_doc_number] => 20160229812
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-11
[patent_title] => 'SALT OF NITROGEN-CONTAINING HETEROCYCLIC COMPOUND OR CRYSTAL THEREOF, PHARMACEUTICAL COMPOSITION, AND FLT3 INHIBITOR'
[patent_app_type] => utility
[patent_app_number] => 15/130168
[patent_app_country] => US
[patent_app_date] => 2016-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11337
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15130168
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/130168 | Salt of nitrogen-containing heterocyclic compound or crystal thereof, pharmaceutical composition, and FLT3 inhibitor | Apr 14, 2016 | Issued |
Array
(
[id] => 14097621
[patent_doc_number] => 20190090486
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-28
[patent_title] => MICROBIOCIDAL OXADIAZOLE DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 16/091859
[patent_app_country] => US
[patent_app_date] => 2016-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34654
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 538
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16091859
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/091859 | Microbiocidal oxadiazole derivatives | Apr 7, 2016 | Issued |
Array
(
[id] => 14699931
[patent_doc_number] => 10377698
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-08-13
[patent_title] => Diphenethylamine derivatives which are inter alia useful as analgesics and method for their production
[patent_app_type] => utility
[patent_app_number] => 15/561614
[patent_app_country] => US
[patent_app_date] => 2016-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14439
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15561614
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/561614 | Diphenethylamine derivatives which are inter alia useful as analgesics and method for their production | Mar 29, 2016 | Issued |
Array
(
[id] => 11010938
[patent_doc_number] => 20160207891
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-21
[patent_title] => 'MALIGNANT AND NON-MALIGNANT DISEASE TREATMENT WITH RAS ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 15/080995
[patent_app_country] => US
[patent_app_date] => 2016-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11534
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15080995
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/080995 | Malignant and non-malignant disease treatment with Ras antagonists | Mar 24, 2016 | Issued |
Array
(
[id] => 12660220
[patent_doc_number] => 20180111906
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-26
[patent_title] => IMPROVED PROCESS FOR PREPARING A STATIN PRECURSOR
[patent_app_type] => utility
[patent_app_number] => 15/561977
[patent_app_country] => US
[patent_app_date] => 2016-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5396
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15561977
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/561977 | IMPROVED PROCESS FOR PREPARING A STATIN PRECURSOR | Mar 23, 2016 | Abandoned |
Array
(
[id] => 12408363
[patent_doc_number] => 09969719
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-15
[patent_title] => Substituted 2-hydrogen-pyrazole derivative serving as anticancer drug
[patent_app_type] => utility
[patent_app_number] => 15/557210
[patent_app_country] => US
[patent_app_date] => 2016-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30963
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15557210
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/557210 | Substituted 2-hydrogen-pyrazole derivative serving as anticancer drug | Mar 9, 2016 | Issued |
Array
(
[id] => 11230892
[patent_doc_number] => 09458112
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-10-04
[patent_title] => 'Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1'
[patent_app_type] => utility
[patent_app_number] => 15/060723
[patent_app_country] => US
[patent_app_date] => 2016-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43494
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15060723
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/060723 | Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1 | Mar 3, 2016 | Issued |
Array
(
[id] => 13196005
[patent_doc_number] => 10112912
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-30
[patent_title] => Homopiperazine-based catalysts for neutralization of organophosphorus-based compounds
[patent_app_type] => utility
[patent_app_number] => 15/059232
[patent_app_country] => US
[patent_app_date] => 2016-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 28
[patent_no_of_words] => 6273
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15059232
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/059232 | Homopiperazine-based catalysts for neutralization of organophosphorus-based compounds | Mar 1, 2016 | Issued |
Array
(
[id] => 12151461
[patent_doc_number] => 20180022723
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-25
[patent_title] => 'NOVEL COMPOUNDS FOR THE TREATMENT OF HEPATITIS C'
[patent_app_type] => utility
[patent_app_number] => 15/551017
[patent_app_country] => US
[patent_app_date] => 2016-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38611
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15551017
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/551017 | Compounds for the treatment of hepatitis C | Feb 18, 2016 | Issued |
Array
(
[id] => 10987360
[patent_doc_number] => 20160184306
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-30
[patent_title] => 'Novel Pyrimidinyl-DiazoSpiro Compounds'
[patent_app_type] => utility
[patent_app_number] => 15/043920
[patent_app_country] => US
[patent_app_date] => 2016-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36063
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15043920
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/043920 | Novel Pyrimidinyl-DiazoSpiro Compounds | Feb 14, 2016 | Abandoned |
Array
(
[id] => 11357317
[patent_doc_number] => 09533959
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-01-03
[patent_title] => 'Methods of regioselective synthesis of 2,4-disubstituted pyrimidines'
[patent_app_type] => utility
[patent_app_number] => 15/043717
[patent_app_country] => US
[patent_app_date] => 2016-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15448
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15043717
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/043717 | Methods of regioselective synthesis of 2,4-disubstituted pyrimidines | Feb 14, 2016 | Issued |
Array
(
[id] => 14031189
[patent_doc_number] => 10227333
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-03-12
[patent_title] => Inhibition of OLIG2 activity
[patent_app_type] => utility
[patent_app_number] => 15/040948
[patent_app_country] => US
[patent_app_date] => 2016-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 74907
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15040948
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/040948 | Inhibition of OLIG2 activity | Feb 9, 2016 | Issued |
Array
(
[id] => 11901905
[patent_doc_number] => 09771329
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-09-26
[patent_title] => 'Inhibitors of lysine specific demethylase-1'
[patent_app_type] => utility
[patent_app_number] => 15/018814
[patent_app_country] => US
[patent_app_date] => 2016-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39851
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15018814
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/018814 | Inhibitors of lysine specific demethylase-1 | Feb 7, 2016 | Issued |
Array
(
[id] => 12138410
[patent_doc_number] => 20180016493
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-18
[patent_title] => 'BLUE FLUORESCENT EMITTERS'
[patent_app_type] => utility
[patent_app_number] => 15/548774
[patent_app_country] => US
[patent_app_date] => 2016-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11921
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15548774
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/548774 | BLUE FLUORESCENT EMITTERS | Feb 3, 2016 | Abandoned |
Array
(
[id] => 12178631
[patent_doc_number] => 20180037568
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-08
[patent_title] => 'MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/549265
[patent_app_country] => US
[patent_app_date] => 2016-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32526
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15549265
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/549265 | MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF | Feb 3, 2016 | Abandoned |
Array
(
[id] => 13424897
[patent_doc_number] => 20180263991
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-20
[patent_title] => COMPLEXES AND SALTS OF DIHYDROPYRIMIDINE DERIVATIVES AND THEIR APPLICATION IN PHARMACEUTICALS
[patent_app_type] => utility
[patent_app_number] => 15/539147
[patent_app_country] => US
[patent_app_date] => 2016-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18319
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15539147
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/539147 | Complexes and salts of dihydropyrimidine derivatives and their application in pharmaceuticals | Jan 31, 2016 | Issued |
Array
(
[id] => 12151445
[patent_doc_number] => 20180022710
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-25
[patent_title] => 'ISOTOPOLOGUES OF 2-(TERT-BUTYLAMINO)-4-((1R,3R,4R)-3-HYDROXY-4-METHYLCYCLOHEXYLAMINO)-PYRIMIDINE-5-CARBOXAMIDE'
[patent_app_type] => utility
[patent_app_number] => 15/546885
[patent_app_country] => US
[patent_app_date] => 2016-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10940
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15546885
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/546885 | ISOTOPOLOGUES OF 2-(TERT-BUTYLAMINO)-4-((1R,3R,4R)-3-HYDROXY-4-METHYLCYCLOHEXYLAMINO)-PYRIMIDINE-5-CARBOXAMIDE | Jan 27, 2016 | Abandoned |
Array
(
[id] => 12125020
[patent_doc_number] => 20180008605
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-11
[patent_title] => 'PTERIDINE DIONE MONOCARBOXYLATE TRANSPORTER INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 15/545152
[patent_app_country] => US
[patent_app_date] => 2016-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 19104
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15545152
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/545152 | Pteridine dione monocarboxylate transporter inhibitors | Jan 21, 2016 | Issued |
Array
(
[id] => 14119157
[patent_doc_number] => 10246423
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-02
[patent_title] => Process for preparing statin precursor
[patent_app_type] => utility
[patent_app_number] => 15/545682
[patent_app_country] => US
[patent_app_date] => 2016-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4312
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15545682
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/545682 | Process for preparing statin precursor | Jan 21, 2016 | Issued |
Array
(
[id] => 10791453
[patent_doc_number] => 20160137610
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-19
[patent_title] => 'Compounds that Modulate EGFR Activity and Methods for Treating or Preventing Conditions Therewith'
[patent_app_type] => utility
[patent_app_number] => 15/001923
[patent_app_country] => US
[patent_app_date] => 2016-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 33320
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15001923
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/001923 | Compounds that Modulate EGFR Activity and Methods for Treating or Preventing Conditions Therewith | Jan 19, 2016 | Abandoned |